St. Jude Brings Remote Monitoring System To Pacemakers
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical's Merlin.net Patient Care Network monitoring system now supports all three types of cardiac rhythm management devices, following FDA approval of St. Jude's Accent RF pacemaker and Anthem RF cardiacresynchronization therapy pacemaker (CRT-P)
You may also be interested in...
New Product Briefs
Hologic: Company expects to launch its new radiation therapy system by the end of the year, having secured FDA clearance Aug. 27, Hologic announced Sept. 1. MammoSite ML is a multi-lumen version of the firm's original, single-lumen MammoSite system, cleared in 2002. The accelerated partial breast irradiation (APBI) devices provide targeted breast cancer radiation therapy directly to the area where cancer is most likely to recur by inflating a balloon catheter containing radioactive material into the surgical cavity after the tumor is removed. The multi-lumen model allows oncologists to shift the radiation dose to the areas within the cavity that need it most, the firm explains. Hologic obtained the MammoSite technology when it bought Cytyc for $6.2 billion in 2007 (1"The Gray Sheet" May 28, 2007)
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.